Abstract:Abstract Abstract 2515 Objective: Phytosterolemia is a rare autosomal recessive sterol storage disease, characterized by increased serum concentrations of plant sterols (phytosterols). It is caused by gene mutations of ABCG5 and ABCG8. The patients suffer from xanthomas and premature atherosclerosis. In this study we demonstrate that macrothrombocytopenia and hemolysis are intrinsic features in four unrelated patients with phytosterolemia, and their clinical and pathogenesis are investigated. Methods: Erythrocyte and platelet morphology was examined under light microscope. Platelet aggregation was measured turbidometrically. Platelet glycoproteins were analyzed using flow cytometry. Biochemistry was analyzed by routine methods. The plasma sterol levels were measured by HPLC method. ABCG5 and ABCG8 genes were directly sequenced to identify mutations, Restriction endonuclease analysis was used to exclude the possibility of gene polymorphism. Result: All the four patients presented xanthomas, macrothrombocytopenia, hemolysis and splenomegaly. The blood smears showed large platelets, some as large as erythrocytes and abnormal erythrocyte shapes, such as stomatocytes. All the patients had bleeding tendency. There were mild defect in aggregation induced by ADP and ristocetin. The red cells showed an increased osmotic fragility. Plasma concentrations of phytosterols including sitosterol, stigmasterol and cholestanol were markedly elevated (30 fold) in the affected patients. Patient 1 was found to be homozygous for C→T mutation at nucleotide 64 in exon 1 of the ABCG5 gene, which results in the premature termination of the ABCG5 protein at amino acid 22 (Gln22X). Patient 2 was homozygous for C→T mutation at nucleotide 1336 in exon 10 of the ABCG5 gene, which results in the premature termination of the ABCG5 protein at amino acid 446 (Arg446X). Patient 3 was compound heterozygous for a large fragment deletion at nucleotide 1842 to 1883 in exon 12, and a complex mutation of del 1938C–1939G/ins1938T in exon 13 of ABCG8. Patient 4 was also compound heterozygous for C→T mutation at nucleotide 1336 in exon 10 and A→G mutation at classical cut locus in intron 9. Conclusion: In this study, we identified four patients with phytosterolemia who had macrothrombocytopenia and stomatocytic hemolysis in addition to common increased plasma plant sterols and xanthomas. Gene analysis confirmed the diagnosis. We suggest that the coexisting macrothrombocytopenia and stomatocytic hemolysis represent a new subtype of phytosterolemia, and plasma phytosterols should be measured in patients who have stomatocytic hemolysis and macrothrombocytopenia (so called“Mediteranean macrothrombocytopenia/ stomatocytosis”). Disclosures: No relevant conflicts of interest to declare.

Xenosterolemia in clinical practice: what is in a name?

Phytosterols and Their Derivatives: Potential Health-Promoting Uses Against Lipid Metabolism and Associated Diseases, Mechanism, and Safety Issues.

Opportunistic Detection of Phytosterolaemia during Genetic Testing for FH: Case Series and Contextual Review

Dietary Sterols and Sterol Oxidation Products on Atherosclerosis: an Insight Provided by Liver Proteomic and Lipidomic.

A Phytosterolemia Patient Presenting Exclusively With Macrothrombocytopenia And Stomatocytic Hemolysis

Evaluation of plasma phytosterols in sitosterolemia, their kindreds and hyperlipidemia subjects

Macrothrombocytopenia And Hemolysis Associated With Phytosterolemia.

Investigating sitosterolemia to understand lipid physiology

Modifying Serum Plant Sterol Concentrations: Effects on Markers for Whole Body Cholesterol Metabolism in Children Receiving Parenteral Nutrition and Intravenous Lipids

The effect of phytosterol supplementation on lipid profile: A critical umbrella review of interventional meta‐analyses

Phytosterols in human serum as measured using a liquid chromatography tandem mass spectrometry

[Clinical Features of 20 Patients with Phytosterolemia Causing Hematologic Abnormalities].

A Sterol Panel for Multiple Rare Lipid Disorders: Validation and Application for Sitosterolemia, Cerebrotendinous Xanthomatosis and Smith-Lemli-Opitz Syndome

Familial Hypercholesterolemia: Current Limitations and Future Breakthroughs

Effects of phytosterol supplementation on lipid profiles and apolipoproteins: A meta-analysis of randomized controlled trials

Sterols in Inflammatory Diseases: Implications and Clinical Utility

[Clinical and Gene Study of Three Pedigrees of Phytosterolemia Associated with Macrothrombocytopenia and Hemolysis].

Abstract 13262: Phytosterol Intake and Risk of Coronary Heart Disease in U.S. Men and Women

Lathosterol in plasma measures cholesterol synthesis and identifies the efficiency of dietary phytosterols in reducing the plasma cholesterol concentration

Update on Sitosterolemia and Atherosclerosis